Decade of CEA and CAS

Advances in surgical techniques and stenting devices for CEA over the past several decades have improved the prognosis of patients with carotid stenosis. In the present study, we examined improvements over a decade through a retrospective analysis of carotid interventions from a single hospital registry. Patients receiving CEA or CAS were compared for risk of cerebral infarction detected by magnetic resonance imaging, 30-day vascular morbidity and mortality, and effects on cognitive function during two periods separated by one decade. Data in the dataset contains from demographic data, outcomes (findings on control brain magnetic resonance and clinical data) and results of cognitive tests.THIS DATASET IS ARCHIVED AT DANS/EASY, BUT NOT ACCESSIBLE HERE. TO VIEW A LIST OF FILES AND ACCESS THE FILES IN THIS DATASET CLICK ON THE DOI-LINK ABOV

Carotid plaques - 3 years analysis

Indentify the factoprs influencing the carotid plaque progresssion. All consecutive patients from the ANTIQUE study (Atherosclerotic Plaque Characteristics Associated with a Progression Rate of the Plaque and a Risk of Stroke in Patients with the Carotid Bifurcation Plaque Study – ClinicalTrials.gov Identifier: NCT02360137) who underwent all clinical and ultrasound examinations over a 36-month period were included in the analysis. The ANTIQUE study inclusion criteria were as follows: patient age 30–90 years; atherosclerotic plaque localized in the carotid bifurcation or proximal part of the internal carotid artery with a width of ≥2.0 mm in B-mode transverse plane; sufficient image quality of atherosclerotic plaque in the carotid bifurcation and internal carotid artery (ICA) using ultrasound; self-sufficiency defined as a modified Rankin Scale score of 0–2 points; and signed informed consent was provided. Exclusion criteria were serious disease with a low probability of survival for at least three years and other objective obstacles preventing regular six-month ultrasound scans. Clinical examination All patients underwent neurological and physical examinations at six-month intervals over the course of 36 months. The examinations included blood pressure (one measurement at rest after the sonographic examination), height, and weight measurements (including calculation of body mass index), collection of demographic and medical data (age, gender, and medical history), occurrence of diseases (arterial hypertension, diabetes mellitus, hyperlipidemia, coronary heart disease, atrial fibrillation, myocardial infarction, or other cardiac diseases; stroke, including stroke type; and surgery or stenting of any vessels, including carotid arteries, coronary, or lower limb and other arteries), smoking, daily alcohol consumption dose, and medication use. Treatment All patients were treated using the “treating arteries instead of risk factors” strategy

CERCAS Trial

The purpose of the study is to compare the safety and effectiveness of carotid endarterectomy with stent removal (CEASR) and repeat percutaneous transluminal angioplasty with or without stenting (rePTA/S) in patients with carotid in-stent restenosis. Consecutive patients with carotid in-stent restenosis (≥80%) were randomly allocated to the CEASR or rePTA/S group. The incidence of residual stenosis after intervention, stroke, transient ischemic attack myocardial infarction and death 30 days and 1 year after intervention and restenosis 1 year after intervention between patients in CEASR and rePTA/S groups were statistically evaluated. All demographic data of enrolled patients and study results data are in the dataset.THIS DATASET IS ARCHIVED AT DANS/EASY, BUT NOT ACCESSIBLE HERE. TO VIEW A LIST OF FILES AND ACCESS THE FILES IN THIS DATASET CLICK ON THE DOI-LINK ABOV